Inflammation covertly rewires the bone marrow, enabling mutated stem cells to rise and setting the stage for future blood disease.

Taken together, these advances suggest that part of age-related immune decline is driven by specific, potentially reversible ...

Scientists say special immune cells in the body can damage bone marrow over the years and contribute to leukaemia, a ...

Hairy-cell leukemia (HCL) is a rare, indolent neoplasm of mature B cells with hairlike surface projections that circulate in the blood and preferentially infiltrate the bone marrow and spleen. The ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...

B-PLL is a rare subtype that’s more aggressive than other blood cancers and has a low survival rate. However, ongoing research and clinical trials may offer new treatment options to improve outcomes.

Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from ...